
GC13236
ACT-132577
Also known as 5-(4-bromophenyl)-4-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-6-(sulfamoylamino)pyrimidine
ACT-132577 (ACT-132577) is the major and pharmacologically active metabolite of Macitentan
ChemicalCAS1103522-45-7MW546.19FormulaC16H14Br2N6O4S
- CAS number
- 1103522-45-7
- Molecular weight
- 546.19
- Formula
- C16H14Br2N6O4S
- Solubility
- DMSO : 25 mg/mL (45·77 mM; ultrasonic and warming and heat to 60°C)
- InChIKey
- DKULOVKANLVDEA-UHFFFAOYSA-N
- Catalogue number
- GC13236
- Brand
- GLPBIO
Computed properties PubChem CID 25099191 · XLogP 2.4 · TPSA 151 Ų · H-bond donors 2
- XLogP
- 2.4
- TPSA
- 151 Ų
- H-bond donors
- 2
- H-bond acceptors
- 10
- Rotatable bonds
- 8
- Heavy atoms
- 29
SMILES C1=CC(=CC=C1C2=C(N=CN=C2OCCOC3=NC=C(C=N3)Br)NS(=O)(=O)N)Br
Computed descriptors from PubChem (CID 25099191), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il